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1. Introduction
In the field of cardiology, some of the most dramatic advances in recent years 
have come from understanding the molecular and cellular basis of cardiovascular 
disease. The knowledge of the pathological basis of disease in some cases allows 
the development of new strategies for prevention and treatment. This book was 
planned not only to convey the new facts of cardiovascular diseases but also to boost 
the excitement and challenges of research in the dynamic area of modern molecular 
and cellular biology of cardiology.
2. Cardiomyocyte: structure and function
Cells are the fundamental unit of life, and the large number of them reflects 
the diversity of their function. The myocardium is composed principally of spe-
cialized muscle cells called cardiomyocytes. The major components of cardiac 
myocytes, cell membrane (sarcolemma) and T-tubules, necessary in excitation-
contraction coupling, thereby facilitate a fast and synchronous contraction across 
the entire cell volume, sarcoplasmic reticulum, nucleus, and contractile elements. 
Cardiomyocytes contain many more mitochondria than skeletal muscle cells reflect-
ing the dependence of cardiac muscle cell on aerobic metabolism. The functional 
intracellular contractile unit of cardiac muscle is the sarcomere that contains the 
contractile proteins myosin and actin. Sarcomeres also contain the regulatory pro-
teins troponin and tropomyosin. Functional integration of myocytes is mediated by 
intercalated disks, which join individual cells and within which specialized intercel-
lular junctions permit mechanical and electrical coupling. Intercalated disk contains 
various junctional complexes including the zonula adherens, desmosomes, and gap 
junctions. One of the most important types of adhesive interactions required for 
the formation and maintenance of tissues is that mediated by the cadherin family. 
The expression and distribution of many of these junctional components are often 
perturbed in cardiovascular disease [1–4]. One of the components of intercalated 
disks is gap junctions which facilitate synchronous myocyte contraction by provid-
ing electrical coupling. Deregulation of gap junction in cardiovascular disease may 
contribute to electromechanical dysfunction and arrhythmias. In addition, the 
cardiac conduction system consists of specialized myocardial fibers that conduct 
electrical impulses more readily than surrounding myocardial fibers and regulate 
the rate and the rhythm of the heart.
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3. Cardiomyocyte: the basis of life and cardiac disease
The etiology of heart failure involves the interaction of multiple parameters, such 
as genetic predisposition, environment factors, and chance. Research advances and 
clinical investigations recognized familial transmission for many cardiomyopathies 
and confirmed the hypothesis that cardiomyopathies are characterized as genetic 
disorders. Numerous theories regarding the cause of idiopathic dilatative cardiomy-
opathy have been proposed such as viral myocarditis, autoimmune response against 
myocardial epitopes, and genetic factors that appear to be more important than 
previously believed. Nowadays, studies based on a more careful evaluation of disease 
inheritance and on prospective systematic family screening revealed a high fre-
quency of genetic transmission of the disease in different populations. However, the 
true frequency is probably still underestimated due to the absence of early markers 
of the disease and reduced penetrance. Mutations in several known genes including 
those encoding dystrophin, δ-sarcoglycan, troponin T, β-myosin heavy chain, actin, 
lamin A/C, and desmin have been identified as a cause of a phenotype [3, 5, 6].
Cells are poised between survival and apoptosis, and their fate rests on a balance 
of powerful intracellular and extracellular forces, whose signals constantly act upon 
and counteract each other. In many circumstances, apoptosis is a self-protective 
programmed mechanism that leads to the suicide of a cell when its survival is 
deemed detrimental to the organism. In other instances, apoptosis is a pathological 
process that contributes to many disorders. Although increasing experiment data 
suggest that necrosis and apoptosis occur in heart failure, the relation between 
the two conditions and the relevant pathophysiological mechanism are less clear. 
Significant progress has been made in demonstrating the role of apoptosis in 
various heart diseases and in elucidating the molecular mechanisms of cardiac 
apoptosis. The progressive loss of cardiac myocytes is one of the most important 
pathogenic components of the heart failure. Even though the rate of apoptosis 
in heart failure is relatively low in absolute numbers, it is significantly higher 
than that in the normal heart, which has essentially negligible baseline apoptosis. 
Recently, animal models of heart failure incorporating transgenic technology have 
confirmed that myocyte apoptosis itself is sufficient to induce heart failure. The 
elevated presence of p53, Bax, and Bak-positive cells in dilated cardiomyopathy is 
associated with progressive loss of myocytes in heart failure. On the other hand, 
increased expression of the antiapoptotic protein bcl-2 in the human myocardium 
with dilated cardiomyopathy may be a compensation for the loss of myocytes 
and a possible compensatory antiapoptotic mechanism in the diseased group. 
Furthermore, the elevated expression of proapoptotic proteins is associated with 
the progressive loss of myocytes by apoptosis and may play a role in the evolution 
of the chronic heart failure in patients with old myocardial infarction and chronic 
ischemic disease. Immunohistochemistry of proapoptotic Bax and antiapoptotic 
bcl-2 protein demonstrated higher levels of both of these proteins in the diseased 
group of patients with acute myocardial infarction than normal hearts. A 1.3- and 
twofold increase in Bax and bcl-2 positive samples was observed in diseased group 
with acute myocardial infarction compared with the control group. The increased 
expression of antiapoptotic proteins in acute myocardial infarction represents a 
possible compensatory mechanism of salvaged myocytes. The prevalence of the 
apoptotic mechanism or this compensatory antiapoptotic may influence the evolu-
tion of heart failure in heart diseases. Thus, the pharmacological manipulation of 
apoptosis represents an active frontier of drug development [7].
Cell and molecular biology is a rapidly growing field of research and transfers 
knowledge, from basic cardiology science and preclinical studies, to the clini-
cal cardiology. At the present time, cell priming, bio-nanotechnology, and tissue 
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engineering are coming up as valuable techniques for cell- and tissue-based therapy 
application in clinical cardiology. The integration of multilevel biological data 
and the connection with the clinical practice reveal the potential of personalized 
medicine and future implications for prognosis, diagnosis, and management of 
cardiovascular diseases.
Author details
Angelos Tsipis1,2
1 Department of Cardiology, Onassis Cardiac Surgery Centre, Athens, Greece
2 Department of Pathology, Medical School, National and Kapodistrian University 
of Athens, Athens, Greece
*Address all correspondence to: angelostsipis@gmail.com
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
4Visions of Cardiomyocyte - Fundamental Concepts of Heart Life and Disease
[1] Cooper GM. The Cell. A Molecular 
Approach. USA: Sinauer Associates Inc.; 
1997. pp. 1-15
[2] Kumar V, Abbas AK, Fausto N. 
Robbins and Cotran: Pathologic Basis of 
Disease. 7th ed. Philadelphia: Elsevier 
Saunders; 2005. pp. 555-557
[3] Tsipis A, Athanassiadou AM, 
Athanassiadou P, Kavantzas N, 
Agrogiannis G, Patsouris E. Apoptosis-
related factors p53, bcl-2 and the 
defects of force transmission in dilated 
cardiomyopathy. Pathology, Research 
and Practice. 2010;206(9):625-630
[4] Kostetskii I, Li J, Xiong Y, Zhou R, 
Ferrari VA, Patel VV, et al. Induced 
deletion of the N-cadherin gene in 
the heart leads to dissolution of the 
intercalated disc structure. Circulation 
Research. 2005;96(3):346-354
[5] Rubin E, Gorstein F, Rubin R,  
Schwarting R, Strayer D. Rubin’s 
Pathology: Clinicopathologic 
Foundations of Medicine. 4th ed. 
Philadelphia: Lippincott Williams & 
Wilkins; 2005. pp. 566-570
[6] Mestroni L, Rocco C, Gregori D.  
Familial dilated cardiomyopathy: 
Evidence for genetic and phenotypic 
heterogeneity. Journal of the 
American College of Cardiology. 
1999;34(1):181-190
[7] Tsipis A. Heart Muscle and 
Apoptosis, Cardiomyopathies - From 
Basic Research to Clinical Management, 
Josef Veselka. IntechOpen; 2012. pp. 
185-198. DOI: 10.5772/29360. Available 
from: https://www.intechopen.com
References
